Poseida Therapeutics
PSTX
#6546
Rank
$0.30 B
Marketcap
$3.19
Share price
3.57%
Change (1 day)
0.31%
Change (1 year)

P/S ratio for Poseida Therapeutics (PSTX)

P/S ratio as of March 2024 (TTM): 4.76

According to Poseida Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.75712. At the end of 2023 the company had a P/S ratio of 4.97.

P/S ratio history for Poseida Therapeutics from 2020 to 2023

PS ratio at the end of each year

Year P/S ratio Change
20234.9742.25%
20223.49-74.39%
202113.6
2020N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA